For instance, in 2022, INCOG BioPharma Services, the Indiana-based contract development and manufacturing organization (CDMO) which specialize in sterile injectables, unveiled that the construction of its manufacturing facility and global headquarters in Fishers, is almost completed.
Contract manufacturing is a form of outsourcing where a manufacturing company enters into an agreement with another manufacturing firm to develop innovative products and services.
Global pharmaceutical & biopharmaceutical contract manufacturing market is segmented into
Based on region, Asia Pacific is expected to register fastest growth during the forecast period owing to improving healthcare infrastructure and availability of highly skilled workforce. Many pharmaceutical companies are setting up their manufacturing units in countries such as China and India, due to low manufacturing and operational costs. Therefore, making Asian countries hub for outsourcing.
Major companies operating in global pharmaceutical & biopharmaceutical contract manufacturing market include Jubilant Pharmova Limited, JRS PHARMA GmbH & Co, Boehringer Ingelheim GmbH, Lonza Group, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, INCOG BioPharma Services, Baxter Biopharma Solutions, Catalent Pharma Solutions, and Kemwell Biopharma Private Limited. Leading companies are continuously carrying out research and development activities to bring new medicines. Also, favourable regulations by government in regions such as Asia Pacific is enabling manufacturers to expand their businesses efficiently.
Objective of the Study
- To analyze and forecast the market size of global pharmaceutical & biopharmaceutical contract manufacturing market.
- To forecast global pharmaceutical & biopharmaceutical contract manufacturing market based on sector, product type, service, drug type and regional distribution.
- To identify drivers and challenges for global pharmaceutical & biopharmaceutical contract manufacturing market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global pharmaceutical & biopharmaceutical contract manufacturing market.
- To identify and analyze the profile of leading players operating in the global pharmaceutical & biopharmaceutical contract manufacturing market.
Download Free Sample Report
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceutical & biopharmaceutical manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.
TechSci Research calculated global pharmaceutical & biopharmaceutical contract manufacturing market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.
Key Target Audience
- Pharmaceutical & biopharmaceutical manufacturers/companies and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to pharmaceutical & biopharmaceutical contract manufacturing
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceutical & biopharmaceutical contract manufacturing companies, partners, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2022 |
| Historical Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Sector · Product Type · Service · Drug Type · Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia; Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Argentina, Colombia; |
| Key companies profiled | Jubilant Pharmova Limited, JRS PHARMA GmbH & Co, Boehringer Ingelheim GmbH, Lonza Group, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, INCOG BioPharma Services, Baxter Biopharma Solutions, Catalent Pharma Solutions, and Kemwell Biopharma Private Limited. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
